1-14 of 14
prostatic neoplasms
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

IL-6 As a Potential Cell Released Marker of Prostate Cancer Cell Death

Zarema Gilazieva, Gulcin Tezcan, Ekaterina Garanina, PhD, Nawar Sakr, Svetlana Arkhipova, Lev Vinogradov, Albert Rizvanov, DSc, PhD, Svetlana Khaiboullina, MD DMS, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4964.
https://doi.org/10.1182/blood-2018-99-116076
Published: 2018
Journal Articles

Protease Activated Receptor-1 (PAR-1) Impedes Tumor Progression

Gregory N. Adams, PhD, Haley Weston, Leah Rosenfeldt, Malinda Frederick, Joseph S. Palumbo, MD
Journal: Blood
Blood (2016) 128 (22): 2560.
https://doi.org/10.1182/blood.V128.22.2560.2560
Published: 2016
Journal Articles

Thrombin and Factor XII Drive Prostate Tumor Growth In Vivo

Gregory Adams, PhD, Leah Rosenfeldt, BS, Malinda Frederick, BS, Keith Kombrinck, MS, Brett P. Monia, PhD, Alexey Revenko, PhD, Joseph S. Palumbo, MD
Journal: Blood
Blood (2015) 126 (23): 424.
https://doi.org/10.1182/blood.V126.23.424.424
Published: 2015
Journal Articles

The Integrin Co-Activator Kindlin-2 Plays a Critical Role In Angiogenesis and Blood Vessel Integrity

Elzbieta Pluskota, PhD, James J Dowling, MD, Ph.D, Natalie Gordon, Jeffrey A Golden, MD, Dorota Szpak, XiaoXia Zhang, Carla Nestor, Yan-Qing Ma, Ph.D, Katarzyna Bialkowska, Ph.D., Tatiana Byzova, PhD, Edward F. Plow, PhD
Journal: Blood
Blood (2010) 116 (21): 4.
https://doi.org/10.1182/blood.V116.21.4.4
Published: 2010
Journal Articles

Discovery of Selective Small Molecule Pan-Pim Kinase Inhibitors with Potent Oral Efficacy in Murine Xenograft Models.

Sean O'Brien, PhD, Mustapha Haddach, PhD, Cosmin Borsan, Jerome Michaux, Pauline Kerdoncuff, Mike Schwaebe, Fabrice Pierre, PhD, Eric Stefan, PhD, Anne Sophie Nedellec, Adam Siddiqui-Jain, PhD, Nicole Streiner, BS, Diwata Macalino, BS, Denis Drygin, Phd, Caroline Ho, MS, Josh Bliesath, BS, May Omori, Ryan Stansfield, BS, Jennifer Phung, David Ryckman, PhD, William Rice, PhD, Kenna Anderes, PhD
Journal: Blood
Blood (2009) 114 (22): 1726.
https://doi.org/10.1182/blood.V114.22.1726.1726
Published: 2009
Journal Articles

Eltrombopag Decreases Proliferation of Ovarian, Lung and Breast Tumor Cell Lines.

Connie L. Erickson-Miller, Jennifer Kirchner, Kodandaram Pillarisetti, Lone Ottesen, Yasser Mostafa Kamel, Yuan Liu, Anne-Marie Martin, Conrad Messam
Journal: Blood
Blood (2009) 114 (22): 2409.
https://doi.org/10.1182/blood.V114.22.2409.2409
Published: 2009
Journal Articles

Thrombin Enhances Spontaneous Tumor Growth and Cell Cycle Activation by Downregulation of p27 Kip1 and Upregulation of Skp2 and MiR-222

Liang Hu, Sherif Ibrahim, Cynthia Liu, Jeffrey Skaar, Michelle Pagano, Simon Karpatkin
Journal: Blood
Blood (2008) 112 (11): 396.
https://doi.org/10.1182/blood.V112.11.396.396
Published: 2008
Journal Articles

Synthetic 15-mer Peptide (PCK3145) Derived from Prostate Secretory Protein with In Vitro and In Vivo Activity Against Non-Hodgkin’s Lymphoma and Other Hematologic Malignancies.

Mireille Guerin, Cynthia Therien, Gorazd Krosl, Jinzi J. Wu, Helene Dulude, Chandra Panchal, Denis-Claude Roy
Journal: Blood
Blood (2007) 110 (11): 1388.
https://doi.org/10.1182/blood.V110.11.1388.1388
Published: 2007
Journal Articles

Mesenchymal Stem Cells as Suicide Gene Therapy Vehicles for Organ-Confined and Metastatic Prostate Cancer (PCa).

Rosetta Martiniello-Wilks, BSc (Hons), PhD, Stephen R. Larsen, MBBS(Hons), Stephane Flamant, BSc (Hons), PhD, Jessamy C. Tiffen, BSc (Hons), Charles G. Bailey, BSc (Hons), PhD, John E.J. Rasko, BSc(Med), MBBS, PhD
Journal: Blood
Blood (2007) 110 (11): 5148.
https://doi.org/10.1182/blood.V110.11.5148.5148
Published: 2007
Journal Articles

Cleaved High Molecular Weight Kininogen (HKa) and Kininostatin (D5) Induce Apoptosis and Inhibit Migration and Invasion of Human Prostate Cancer Cells by Preventing AKT Phosphorylation and Cyclin D1 Synthesis and Disrupting the Interaction of UPAR and EGFR.

Yuchuan Liu, PhD, Robin Pixley, Ph.D., Mario Fusaro, B.S., Robert W. Colman, M.D.
Journal: Blood
Blood (2007) 110 (11): 405.
https://doi.org/10.1182/blood.V110.11.405.405
Published: 2007
Journal Articles

Overexpression and Preferential Nuclear Translocation of the Transcription Factor Yin Yang 1 (YY1) in Human Bone Marrow-Derived Multiple Myeloma.

Sara Huerta-Yepez, PhD, Stravoula Baritaki, PhD, Angeles Hernandez-Cuecto, MD, Yu-Mei Anguino-Hernandez, Mehran Neshat, PhD, Haiming Chen, MD, Richard A. Campbell, Melinda S. Gordon, PhD, James R. Berenson, PhD, Benjamin Bonavida, PhD
Journal: Blood
Blood (2005) 106 (11): 3394.
https://doi.org/10.1182/blood.V106.11.3394.3394
Published: 2005
Journal Articles

Genetically Modified DCs Engineered To Express PSA and/or PSMA Can Induce a Potent Immune Response Against Prostate Cancer Cells.

Jagdeep S. Walia, MBBS, Jianhui Cai, MDPhD, Daniel H. Fowler, MD, Jeffrey A. Medin4, PhD
Journal: Blood
Blood (2005) 106 (11): 3075.
https://doi.org/10.1182/blood.V106.11.3075.3075
Published: 2005
Journal Articles

Reduced Tissue Factor Expression in Rat Prostate Tumor Cells Limits Tumor Development in Vivo.

Hui Song, PhD, Zhong Liang, MA, William Wolter, BS, Mark A. Suckow, DVM, Elliot D. Rosen, PhD
Journal: Blood
Blood (2004) 104 (11): 2978.
https://doi.org/10.1182/blood.V104.11.2978.2978
Published: 2004
Journal Articles

Tissue factor is the receptor for plasminogen type 1 on 1-LN human prostate cancer cells

Mario Gonzalez-Gronow, Govind Gawdi, Salvatore V. Pizzo
Journal: Blood
Blood (2002) 99 (12): 4562–4567.
https://doi.org/10.1182/blood.V99.12.4562
Published: 2002